{"version":"1.0","type":"rich","title":"Donanemab + 2-Pyrazinecarboxamide, N-[3-[(4aR,7aS)-2-amino-6-(5-fluoro-2-pyrimidinyl)-4a,5,6,7-tetrahydropyrrolo[3,4-d][1,3]thiazin-7a(4H)-yl]-4-fluorophenyl]-5-methoxy- for alzheimer disease","provider_name":"What came of it?","provider_url":"https://staging.whatcameofit.com/","html":"<iframe src=\"https://staging.whatcameofit.com/embed/donanemab-2-pyrazinecarboxamide-n-3-4ar-7as-2-amino-6-5-fluoro-2-pyrimidinyl-4a-5-6-7-tetrahydropyrrolo-3-4-d-1-3-thiazin-7a-4h-yl-4-fluorophenyl-5-methoxy--alzheimer-disease\" title=\"Donanemab + 2-Pyrazinecarboxamide, N-[3-[(4aR,7aS)-2-amino-6-(5-fluoro-2-pyrimidinyl)-4a,5,6,7-tetrahydropyrrolo[3,4-d][1,3]thiazin-7a(4H)-yl]-4-fluorophenyl]-5-methoxy- for alzheimer disease\" width=\"440\" height=\"420\" style=\"border:0;max-width:100%\" loading=\"lazy\"></iframe>","width":440,"height":420,"thumbnail_url":"https://staging.whatcameofit.com/brand-card.png?v=b7e2e5c93907","thumbnail_width":1200,"thumbnail_height":630,"cache_age":86400}